For immediate release
Chicago, IL – March 14, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Eli Lilly and Company LLY, Nike, Inc. NKE, Micron Technology Inc. MU, Bayer Aktiengesellschaft BAYRY and Valero Energy Corp. VLO.
Here are highlights from Friday’s analyst blog:
Best analyst reports for Eli Lilly, Nike and Micron Technologies
Zacks Research Daily features top research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company, Nike Inc. and Micron Technology, Inc. These research reports have been handpicked from the approximately 70 reports published by our team of analysts today.
You can see all today’s research reports here >>>
Shares of Eli Lily outperformed the industry Zacks Large Cap Pharmaceuticals over the past year (+29.6% vs. +19.2%). Lilly has a strong pipeline of entry-level medicines in diabetes, autoimmune diseases and cancer. The Zacks analyst believes Lilly’s revenue growth is being driven by increased demand for drugs like Trulicity, Taltz and others.
It regularly adds promising new pipeline assets through business development agreements. It has an exciting pipeline of potential new drugs, including tirzepatide for type II diabetes and donanemab for early-stage Alzheimer’s disease. Both candidates have multi-billion dollar sales potential.
However, generic competition for several drugs, increasing price pressure in the United States, mainly on the key drug, Trulicity, and price reductions in some international markets such as China, Japan and Europe are headwinds.
Nike stocks are down -10.2% over the past year against declines of -10.4% in the Zacks shoe industry and clothing retail. The Zacks analyst believes Nike shares have fallen over the past year on headwinds from supply chain constraints. Declines in Greater China and APLA, and continued impacts from supply chain headwinds in the market partially hurt the company’s revenue in the second quarter of fiscal 2022.
Nike expects volatility in fiscal 2022 due to disruptions caused by COVID variants. However, product innovation, brand strength and scale of company operations are expected to continue to drive digital sales. It remains on track to deliver on its outlook for FY2025.
Shares of Micron have underperformed the S&P 500 index year-to-date (-18.7% vs. -10.5%). The Zacks analyst believes that Micron’s short-term profitability may be affected by its planned salary increases. Additionally, higher customer inventory levels in the cloud, graphics, and enterprise market pose a major threat. Demand for software servers from several enterprise original equipment manufacturer (OEM) customers is also a concern.
However, Micron has already seen growing demand for memory chips from cloud computing providers and accelerating adoption of 5G (fifth generation) cellular networks. The increase in the number of high value-added solutions, improved customer engagement and improved cost structure are also growth drivers. Additionally, the adoption of 5G beyond mobile is likely to drive demand for memory and storage, especially in Internet of Things (IoT) devices and wireless infrastructure.
Other noteworthy reports we’re featuring today include Bayer Aktiengesellschaft and Valero Energy Corp.
Just Released: Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know our top 10 picks for all of 2022?
From its creation in 2012 to 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% vs. +348.7% for the S&P 500. Now our research director has combed through 4,000 companies covered by the Zacks Ranking and selected the top 10 tickers to buy and keep. Don’t miss your chance to enter…because the sooner you do, the better your chances of winning.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. To visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.
Just Released: Zacks Top 10 Stocks for 2022
In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?
Last year 2021 Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.